nerve-regeneration
FAQ's
Answer : According to Precedence Research, the global pharmaceutical manufacturing market size was valued at US$ 357.9 billion in 2020 and is expected to surpass around US$ 1,190.16 billion by 2030.
Answer : The pharmaceutical manufacturing market is anticipated to grow at a noteworthy CAGR of 12.8% during the forecast period 2021 to 2030.
Answer : Factors such as increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, increasing focus on outsourcing manufacturing activities, increasing per capita healthcare expenditure, growing incidence of novel viral diseases, technological advancements in manufacturing processes, and improving reimbursement scenario in developing regions are driving the growth of pharmaceutical manufacturing market.
Answer : In 2019, North America dominated the global market with a market share of more than 41%
Answer : Asia Pacific is estimated to advance at the maximum CAGR of around 15.8% in the forecast period due to high incidence of chronic ailments.
Answer : In-house drug development segment displayed the major share in the worldwide pharmaceutical manufacturing market in 2019.
Answer : The oral route of administration accounted for the largest revenue in the containers segment with more than 68% share in 2020.
Answer : The major companies operating in the worldwide pharmaceutical manufacturing market are GlaxoSmithKline plc, Merck & Co., Inc., Eli Lilly and Company, Johnson & Johnson, F. Hoffmann-La Roche Ltd., Lonza, Pfizer, Inc., Sanofi SA, Novartis AG, and AstraZeneca among others.
Get a Sample of this Report
nerve-regeneration
